Cadrenal Therapeutics Inc. Common Stock

CVKD | NASDAQ

$1.10

+$0.01 (+0.92%)

Sep 22, 2026, 12:41 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
PE Ratio	-1.02	-1.66	-1.15	-7.14
PEG Ratio	0.04	0.18	-0.10	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	4.94	2.38	1.25	-8.64
P/FCF Ratio	-1.07	-2.40	-2.73	-36.40
P/OCF Ratio	-1.07	-2.40	-2.73	-36.47
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	n/a	n/a	0	-0.12
Quick Ratio	2.72	3.77	10.27	0.55
Current Ratio	2.72	3.77	10.27	0.55
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	-446.34	-25.22
Return on Equity	-483.34%	-143.17%	-108.64%	120.95%
Return on Assets	-305.95%	-105.21%	-98.10%	-862.83%
Return on Invested Capital	-491.51%	-147.33%	-98.95%	551.03%
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a